Dr. Kathryn J. Fowler

Physiatry
100 E Carroll St, 
Salisbury, MD 
Clinical Trials:Currently Recruiting for 1 Trial
100 E Carroll St, 
Salisbury, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kathryn Fowler is a Physiatrist in Salisbury, Maryland. Her top areas of expertise are Gallbladder Adenocarcinoma, Gallbladder Disease, Thoracic Outlet Syndrome, Hepatectomy, and Aneurysm Repair.

Her clinical research consists of co-authoring 287 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Physiatry
Licenses
Physical Medicine & Rehabilitation in MD
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

100 E Carroll St, Salisbury, MD 21801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Abbreviated MRI (AMRI) Vs. Ultrasound for HCC Surveillance in Cirrhosis
Abbreviated MRI (AMRI) Vs. Ultrasound for HCC Surveillance in Cirrhosis
Enrollment Status: Recruiting
Publish Date: November 25, 2024
Intervention Type: Drug
Study Drug: Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid
Study Phase: Phase 4
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
Enrollment Status: Completed
Publish Date: November 25, 2024
Early Phase I Evaluation of 64Cu-LLP2A for Imaging Multiple Myeloma
Early Phase I Evaluation of 64Cu-LLP2A for Imaging Multiple Myeloma
Enrollment Status: Terminated
Publish Date: November 12, 2024
Intervention Type: Procedure, Device, Drug
Study Drug: 64Cu-LLP2A
Study Phase: Early Phase 1
Prospective Registry Study of Neoadjuvant Therapy in Conjunction With Liver Transplantation for Cholangiocarcinoma
Prospective Registry Study of Neoadjuvant Therapy in Conjunction With Liver Transplantation for Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: June 15, 2023
Intervention Type: Other
Pilot Study of Hepatic Arterial Infusion Therapy in Patients With Unresectable or Borderline Resectable Intrahepatic Cholangiocarcinoma
Pilot Study of Hepatic Arterial Infusion Therapy in Patients With Unresectable or Borderline Resectable Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors
A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors
Enrollment Status: Terminated
Publish Date: July 08, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Early Assessment of Response to Dual Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma Using 18F-FLT PET/CT and PET/MR
Early Assessment of Response to Dual Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma Using 18F-FLT PET/CT and PET/MR
Enrollment Status: Terminated
Publish Date: July 17, 2019
Intervention Type: Drug, Device
Study Phase: Phase 1
Reproducibility of 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Reproducibility of 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Enrollment Status: Completed
Publish Date: April 05, 2019
Intervention Type: Device, Radiation
Study Phase: Phase 1
Local Ablative Strategies After Endovascular Radioembolization (LASER)
Local Ablative Strategies After Endovascular Radioembolization (LASER)
Enrollment Status: Terminated
Publish Date: August 16, 2018
Intervention Type: Radiation, Device
Study Phase: Phase 1
Pilot Study of Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
Pilot Study of Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
Enrollment Status: Terminated
Publish Date: March 05, 2018
Intervention Type: Device
Study Phase: Phase 1
4D Phase Contrast MR: Validation and Evaluation of Hypertrophy in Liver Cancer
4D Phase Contrast MR: Validation and Evaluation of Hypertrophy in Liver Cancer
Enrollment Status: Terminated
Publish Date: April 07, 2017
Intervention Type: Procedure, Device
Study Phase: Not Applicable
View 10 Less Clinical Trials

285 Total Publications

Understanding Repeatability and Reproducibility Coefficients for Quantitative Imaging Biomarkers.
Understanding Repeatability and Reproducibility Coefficients for Quantitative Imaging Biomarkers.
Journal: Radiology
Published: August 12, 2025
Similar Doctors
Expertise in
9
conditions
Dr. Gunnar W. Zorn
Physiatry
Expertise in
9
conditions
Dr. Gunnar W. Zorn
Physiatry

Ability Rehab Associates

100 E Carroll St, Box 400, 
Salisbury, MD 
 (0.1 miles away)
410-543-7065
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gunnar Zorn is a Physiatrist in Salisbury, Maryland. Dr. Zorn is highly rated in 9 conditions, according to our data. His top areas of expertise are Rhabdomyolysis, Chronic Subdural Hematoma, Subdural Hematoma, and Miller-Fisher Syndrome. Dr. Zorn is currently accepting new patients.

Expertise in
8
conditions
Dr. Mandip S. Parmar
Physiatry
Expertise in
8
conditions
Dr. Mandip S. Parmar
Physiatry

Ability Rehab Associates

100 E Carroll St, Box 400, 
Salisbury, MD 
 (0.1 miles away)
410-543-7065
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mandip Parmar is a Physiatrist in Salisbury, Maryland. Dr. Parmar is highly rated in 8 conditions, according to our data. His top areas of expertise are Rhabdomyolysis, Chronic Subdural Hematoma, Volkmann Contracture, and Miller-Fisher Syndrome. Dr. Parmar is currently accepting new patients.

Expertise in
11
conditions
Dr. Peter J. Coveleski
Physiatry
Expertise in
11
conditions
Dr. Peter J. Coveleski
Physiatry

Cnmri PA

111 Neurology Way, 
Milford, DE 
 (40.1 miles away)
302-422-0800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Coveleski is a Physiatrist in Milford, Delaware. Dr. Coveleski is highly rated in 11 conditions, according to our data. His top areas of expertise are Hemiplegia, Invertebral Disc Disease, Foot Drop, and Frontonasal Dysplasia Klippel Feil Syndrome. Dr. Coveleski is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fowler's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile